These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 16198334)
21. [Ultrasonic cavitation and ozonization in treatment of patients with pyo-necrotic complications of diabetic foot syndrome]. Zubarev PN; Risman BV Vestn Khir Im I I Grek; 2011; 170(1):48-53. PubMed ID: 21506355 [TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease. Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451 [TBL] [Abstract][Full Text] [Related]
23. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats. Chaudhry J; Ghosh NN; Roy K; Chandra R Life Sci; 2007 Feb; 80(12):1135-42. PubMed ID: 17234217 [TBL] [Abstract][Full Text] [Related]
24. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Lucotti P; Setola E; Monti LD; Galluccio E; Costa S; Sandoli EP; Fermo I; Rabaiotti G; Gatti R; Piatti P Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E906-12. PubMed ID: 16772327 [TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes of wide postsurgical lesions in the infected diabetic foot managed with 2 different local treatment regimes compared using a quasi-experimental study design: a preliminary communication. Goretti C; Mazzurco S; Nobili LA; Macchiarini S; Tedeschi A; Palumbo F; Scatena A; Rizzo L; Piaggesi A Int J Low Extrem Wounds; 2007 Mar; 6(1):22-7. PubMed ID: 17344198 [TBL] [Abstract][Full Text] [Related]
27. Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress. Gupta A; Tripathi AK; Tripathi RL; Madhu SV; Banerjee BD Indian J Biochem Biophys; 2007 Oct; 44(5):373-8. PubMed ID: 18341213 [TBL] [Abstract][Full Text] [Related]
28. An Overview of Ozone Therapy for Treating Foot Ulcers in Patients With Diabetes. Wen Q; Chen Q Am J Med Sci; 2020 Aug; 360(2):112-119. PubMed ID: 32534720 [TBL] [Abstract][Full Text] [Related]
29. Mitochondrial DNA oxidation and manganese superoxide dismutase activity in peripheral blood mononuclear cells from type 2 diabetic patients. García-Ramírez M; Francisco G; García-Arumí E; Hernández C; Martínez R; Andreu AL; Simó R Diabetes Metab; 2008 Apr; 34(2):117-24. PubMed ID: 18291700 [TBL] [Abstract][Full Text] [Related]
30. [Using regulatory peptide imunofan in type 2 diabetes mellitus patients with diabetic foot syndrome]. Tutel'ian AV; Iakubovskaia IA; Skrypnik NV; Levedev VV Ter Arkh; 2009; 81(12):16-9. PubMed ID: 20481041 [TBL] [Abstract][Full Text] [Related]
31. Cholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus. Ferderbar S; Pereira EC; Apolinário E; Bertolami MC; Faludi A; Monte O; Calliari LE; Sales JE; Gagliardi AR; Xavier HT; Abdalla DS Diabetes Metab Res Rev; 2007 Jan; 23(1):35-42. PubMed ID: 16634125 [TBL] [Abstract][Full Text] [Related]
32. The dual action of ozone on the skin. Valacchi G; Fortino V; Bocci V Br J Dermatol; 2005 Dec; 153(6):1096-100. PubMed ID: 16307642 [TBL] [Abstract][Full Text] [Related]
33. Clinical reversal of root caries using ozone: 6-month results. Baysan A; Lynch E Am J Dent; 2007 Aug; 20(4):203-8. PubMed ID: 17907479 [TBL] [Abstract][Full Text] [Related]
34. Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis. Agrillo A; Ungari C; Filiaci F; Priore P; Iannetti G J Craniofac Surg; 2007 Sep; 18(5):1071-5. PubMed ID: 17912085 [TBL] [Abstract][Full Text] [Related]
35. [Bio-inductive effects of inorganic elements on skin wound healing]. Zhou LS; Liao ZJ; Zhang Q; Luo M; Lu G; Zhang W Zhonghua Shao Shang Za Zhi; 2005 Oct; 21(5):363-6. PubMed ID: 16383040 [TBL] [Abstract][Full Text] [Related]
36. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Sorrentino SA; Bahlmann FH; Besler C; Müller M; Schulz S; Kirchhoff N; Doerries C; Horváth T; Limbourg A; Limbourg F; Fliser D; Haller H; Drexler H; Landmesser U Circulation; 2007 Jul; 116(2):163-73. PubMed ID: 17592079 [TBL] [Abstract][Full Text] [Related]
37. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Stirban A; Negrean M; Stratmann B; Gawlowski T; Horstmann T; Götting C; Kleesiek K; Mueller-Roesel M; Koschinsky T; Uribarri J; Vlassara H; Tschoepe D Diabetes Care; 2006 Sep; 29(9):2064-71. PubMed ID: 16936154 [TBL] [Abstract][Full Text] [Related]
38. [Influence of intravenous ozone treatment on the level of different specificity antibodies]. Mandzhgaladze NR; Kharebava ER; Didia TsG; Ardzhevanishvili MD; Gudzhabidze MV; Chigiashvili TsN Georgian Med News; 2006 Sep; (138):93-5. PubMed ID: 17057311 [TBL] [Abstract][Full Text] [Related]
39. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications. Colak E; Majkić-Singh N; Stanković S; Srecković-Dimitrijević V; Djordjević PB; Lalić K; Lalić N Ann Med; 2005; 37(8):613-20. PubMed ID: 16338763 [TBL] [Abstract][Full Text] [Related]
40. Lipid peroxidation and serum antioxidant enzymes in patients with type 2 diabetes mellitus. Ahmed FN; Naqvi FN; Shafiq F Ann N Y Acad Sci; 2006 Nov; 1084():481-9. PubMed ID: 17151323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]